Covered recipient · General Payments record
CHADD TODD
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$854.08
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $405.59 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $221.20 | 18 |
| PFIZER INC. | $56.51 | 3 |
| Novo Nordisk AS | $55.88 | 3 |
| Lilly USA, LLC | $42.95 | 2 |
| Acerta Pharma LLC | $29.05 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.57 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229439 | CMS |
| ABBVIE INC. | $22.93 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229441 | CMS |
| ABBVIE INC. | $7.56 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229443 | CMS |
| ABBVIE INC. | $7.23 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229445 | CMS |
| ABBVIE INC. | $13.68 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229447 | CMS |
| ABBVIE INC. | $18.70 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229449 | CMS |
| ABBVIE INC. | $18.59 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229451 | CMS |
| ABBVIE INC. | $7.74 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229453 | CMS |
| ABBVIE INC. | $4.44 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229455 | CMS |
| ABBVIE INC. | $4.67 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229457 | CMS |
| ABBVIE INC. | $17.42 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229459 | CMS |
| ABBVIE INC. | $24.73 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229461 | CMS |
| ABBVIE INC. | $2.48 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229463 | CMS |
| ABBVIE INC. | $8.59 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229465 | CMS |
| ABBVIE INC. | $4.80 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229467 | CMS |
| ABBVIE INC. | $16.34 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229469 | CMS |
| ABBVIE INC. | $4.81 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229471 | CMS |
| ABBVIE INC. | $5.92 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229473 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.83 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105823443 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.22 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105453549 | CMS |
| Lilly USA, LLC | $18.80 | 05/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136107385 | CMS |
| Lilly USA, LLC | $24.15 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136093202 | CMS |
| Novo Nordisk Inc | $23.69 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097394297 | CMS |
| Novo Nordisk Inc | $17.95 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096963079 | CMS |
| Novo Nordisk Inc | $14.24 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096591019 | CMS |
| PFIZER INC. | $20.00 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131219551 | CMS |
| PFIZER INC. | $16.55 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131569488 | CMS |
| PFIZER INC. | $19.96 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132111119 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.